Target discovery helps identifying drug targets, molecules or molecular interactions at a critical point in a disease-causing pathway that are predicted to being amenable to therapeutic manipulation. The centre aims to link recent advances in genetics, genomics, cell and chemical biology for improved drug target discovery. A more specific focus for refining and validating such targets will provide a better link between traditional "open ended" academic processes to biomedical research and the need of the pharmaceutical industry for accurately defined targets to accelerate drug development.
Professor Derrick Crook joins Public Health England (PHE) as Director of Microbiology on 1 January 2015. He is currently Professor of Microbiology in the Nuffield Department of Medicine at Oxford University and is a practicing clinical microbiologist and infectious diseases physician at the Oxford University Hospitals NHS Trust.